Learn more about clinical evidence for anorectal surgical and diagnostic procedures
Early quality of life outcomes following Doppler guided transanal haemorrhoidal dearterialisation: a prospective observational study - Early quality of life outcomes following Doppler guided transanal haemorrhoidal dearterialisation: a prospective observational study
Early quality of life outcomes following Doppler guided transanal haemorrhoidal dearterialisation: a prospective observational study
Talha S., Burke J.P., Waldron D. et al Acta Gastroenterol Belg. 2013 Jun;76(2):231-4
- online source https://www.ncbi.nlm.nih.gov/pubmed/23898561
BACKGROUND AND AIMS:
There are few studies examining the quality of life (QOL) of patients with haemorrhoidal disease. Transanal heamorrhoidal dearterialization (THD) is a treatment modality for heamorrhoidal disease in which a Doppler transducer is used to locate the supplying arteries that are subsequently ligated. The aim of this study was to assess symptoms and QOL changes following THD.
PATIENTS AND METHODS:
This was a prospective evaluation of QOL and symptom changes following THD. Patient symptoms, demographics and QOL were recorded preoperatively and 1-month post-operatively following THD using the medical outcomes study short-form-36 (SF-36).
Thirteen patients undergoing THD were evaluated. One month following THD symptoms of haemorrhoid protrusion, bleeding, anal pain, painful defaecation, constipation and tenesmus, had all significantly reduced (P <0.05). Limitations in usual role activities because of physical health problems (53.8 +/- 10.5 Vs 90.4 +/-4.5, P = 0.004), vitality, energy and fatigue (45 +/- 6.9 Vs 73.5 +/- 5.0, P= 0.003), general mental health, psychologic distress and wellbeing (60.9 +/- 6.9 Vs 83.1 +/- 5.9, P= 0.023), limitations in social activities because of physical or emotional problems (58.7 +/- 8.8 Vs 84 +/- 5.9, P = 0.025), and physical pain (52.9 +/- 7.9 Vs 84.6 +/- 6.4, P= 0.005) scores had all improved 1-month following THD.
THD significantly reduces symptoms of haemorrhoidal disease and improves specific aspects of QOL 1-month following surgery.